
-
11/06/2018
PAION announces successful completion of Russian remimazolam Phase III clinical trial by Partner R-Pharm
-
10/08/2018
PAION announces clinical development progress with remimazolam by its partner Hana Pharm in South Korea
-
09/12/2018
PAION announces attendance at four upcoming conferences
-
08/08/2018
PAION AG reports financial results for the first half-year of 2018
-
07/24/2018
PAION starts EU Phase III trial with remimazolam in general anesthesia
-
06/21/2018
PAION AG raises EUR 5.2 million in private placement
-
05/22/2018
PAION announces attendance at two upcoming conferences
-
05/17/2018
PAION announces clinical development progress with remimazolam by its partner R-Pharm in Russia
-
04/05/2018
PAION participates at three upcoming conferences
-
03/22/2018
PAION announces clinical development progress with remimazolam by its partner Hana Pharm in South Korea
-
03/22/2018
PAION AG reports on fiscal year and financial results 2017
-
02/08/2018
PAION to present at three upcoming conferences